When looking for the best stocks to buy and watch, focus on those with rising relative price strength.
One stock that fits that bill is Agios Pharmaceuticals stock , which saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 65 to 93.
When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength. IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the best-performing stocks often have an RS Rating of over 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Agios Pharmaceuticals Stock A Buy?
Agios Pharmaceuticals stock recently retook its 200-day moving average. Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to establish and enter a buy zone in heavy volume.
Taking a look at top and bottom line numbers, the biotech company has posted two quarters of accelerating earnings growth. Revenue growth has been a different story, coming in at -100% last quarter.
Agios Pharmaceuticals stock holds the No. 133 rank among its peers in the Medical-Biomed/Biotech industry group. Catalyst Pharma, Genmab and Vertex Pharmaceuticals are among the top 5 highly rated stocks within the group. For more industry news, check out "Biotech And Pharmaceutical Industry And Stock News."
